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Although  non-innervated,  the placenta  contains  both  cholinesterases  (ChEs),  butyryl-
cholinesterase  (BChE)  and  acetylcholinesterase  (AChE).  These  enzymes  are  well-known  for
their  multiple  molecular  forms.  In a ﬁrst approach,  we  used  recognized  speciﬁc  inhibitors,
substrate  preferences  and  non-denaturating  gel  electrophoresis  in order  to characterize  the
ChE  proﬁle  of term  placenta  from  uncomplicated  pregnancy.  Results  strongly  suggest  that
the predominant  cholinesterasic  form  present  was  tetrameric  BChE.
It is  well  established  that  both  ChEs  are targets  of cholinesterase-inhibiting  organophos-
phates  (OP),  one  of the  most  important  classes  of  chemicals  actively  applied  to  the
environment.  However,  we  have  previously  reported  increased  ChEs  activity  in  placenta  of
rural  residents  exposed  to  OP.  In the present  work,  we  have studied:  1) whether  this  ﬁnd-
ing  was  reproducible  and,  2) whether  AChE  or BChE  up  regulation  is behind  the  increase  of
placental ChE  activity.  The  population  studied  included  forty  healthy  women  who  live  in
an agricultural  area.  Samples  were  collected  during  both  the  OP  pulverization  period  (PP)
and  the  recess  period  (RP). The  placental  ChEs  activity  increased  in  PP,  evidencing  repro-
ducibility  of  previous  results.  The  analysis  of non-denaturating  gels  revealed  that  increased
activity  of  total  ChE  activity  in  placenta  from  women  exposed  to OP may  be attributable  to
tetrameric  BChE  up-regulation.
©  2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
the  CC  BY-NC-N
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1. Introduction
Humans have two cholinesterases (ChEs): acetyl-
cholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase
(BChE, EC 3.1.1.8). The enzymatic functions of both
enzymes include hydrolysis of acetylcholine ACh [1]. At
the nerve synapses, AChE terminates nerve impulse trans-
mission by hydrolyzing this neurotransmitter. On the other
hand, BChE acts as a backup for AChE and as a scavenger for
poisons that might inhibit AChE activity [2]. These enzymes
have been very rapidly distinguished and subject of consid-
erable research [3].
is is an open access article under the CC BY-NC-ND license
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AChE and BChE are well-known for their multiple
molecular forms [4]. Polymorphism is achieved by cer-
tain combinations of alternative gene splicing, and by
the attachment of non-catalytic structural subunits. In
mammals, AChE is encoded by a single gene. However,
alternative splicing at the C-terminus of AChE mRNA
generates three different isoforms. Conversely, one BChE
transcript has been identiﬁed so far [5].
The presence of ChEs in tissues that are not choliner-
gically innervated provides the most compelling evidence
that both AChE and BChE might have functions, other than
the termination of cholinergic neurotransmission [6]. In
fact, the human placenta contains an active cholinergic
system which was associated to the amino acid uptake,
the release of human placental chorionic somatotropin
and prostaglandin production [7] and to the modulation
of nitric oxide effect [8].
The concentrations of AChE and BChE are consider-
ably lower in the placenta than in the nervous system [9].
The analysis by electron microscopy of cross sections from
term placenta, cytochemically stained for ChEs activities,
showed that term placenta syncytiotrophoblast cells pro-
duce primarily AChE. On the other hand, epithelial cells
that surround the inner part of blood vessels, as well as
hematopoietic cells present in them, all intensely stained
for both AChE and BChE activities [10]. In accordance with
these observations, it was reported that both AChE and
BChE activities were detectable in cultured explanted vil-
lous of term placenta [11].
Depending on the experimental conditions used, dis-
similar OP effects on placental AChE activity have been
reported. Gestational exposure of rats to oral doses of
the OP chlorpyrifos cause no inhibition of AChE activity
[12], while a single cutaneous dose of OP in pregnant rats
decreased AChE activity [13]. Nevertheless, we previously
reported increased ChE activity in human placenta associ-
ated to OP environmental exposure [14].
Considering that AChE up regulation was induced post
OP-treatment in rodents brain [3,15], muscle [16] and
plasma [17], we speculate that an adaptive change could
explain our previous ﬁnding.
The objective of the present study was to verify the
reproducibility of the increased placental ChE activity asso-
ciated to OP environmental exposure and to determine
whether AChE up regulation is behind this ﬁnding. In
addition, we also characterized placental ChEs activity in
control samples using recognized speciﬁc inhibitors.
2. Materials and methods
2.1. Chemicals
Acetylthiocholine (ASCh) iodide, butyrylthiocholine
(BSCh) iodide, 5,5′-dithio-bis (c-nitrobenzoic acid) (DTNB),
eserine hemisulfate salt, tetraisopropylpyrophosphora-
mide (iso-OMPA), 1,5-bis (4-allyldimethyl ammonium-
phenyl)-pentan-3-one dibromide (BW284C51), HEPES (4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid), EDTA
(etilen diamino-tetracetic acid), boric acid, bovine serum
albumin, Tris, glycerol, bromophenol blue, maleic acid,
sodium citrate dihydrate, copper pentahydrate, potassiumorts 2 (2015) 437–442
ferricyanide, cholinesterase acetyl (True Cholinesterase
EC 3.1.1.7) Type V-S from Electric Eel, acrylamide,
tetramethylenediamine and ammonium persulfate were
purchased from SIGMA. Sodium dodecyl sulphate (99%
pure) and ethanol (99% pure) were purchased from MERCK
(Germany). Bisacrylamide was  acquired from PROMEGA.
2.2. Participant recruitment and collection of samples
We  performed a study of 40 healthy women ranging
between 15 and 36 years of age incoming to prena-
tal care at the Cinco Saltos Public Hospital (Río Negro
Province, Argentina), between December 2006 and August
2008. They were asked by a physician to participate in
the study during their third trimester of pregnancy and,
informed consent was  obtained from each participant
before they were interviewed. This study was carried out
with the full ethical approval of the local Advisory Com-
mittee of Biomedical Research in Humans. The patients
included in this study were residents of farms or commu-
nities surrounding fruit cultivation areas where pesticides,
such as the OPs azinphos methyl, phosmet, chlorpyrifos
and dimethoate, are applied during the spring and sum-
mer  (September to February). Pesticides are usually ﬁnely
dispersed as droplets at the time of pulverization and
aerial drift from the target area is frequently, increasing
the potential environmental exposure of the population.
Samples collected from September to December were con-
sidered samples from the PP, and those collected from
April to August were considered samples from the non-
pulverization period or recess period (RP). A questionnaire
was  administered to document physical characteristics,
educational level and lifestyle habits. Women  with chronic
diseases, on long-term medication (except those included
in Group A according to the FDA), and those with seri-
ous pregnancy complications were excluded. Groups were
matched for reported smoking habit and alcohol con-
sumption. Placental villous samples were collected within
20 min  of vaginal delivery. Suitable amounts from the cen-
tral area of the maternal side of the placenta were obtained
as the expression of various components that might vary
according to the location. Samples were frozen at −20 ◦C
until use.
In addition, placentas from urban residents with
no history of pesticide exposure were collected during
July–August 2006 to characterize placental ChEs activity.
Similar exclusion criteria as those of the population study
were used. Also, the full the local Advisory Committee of
Biomedical Research in Humans approved this part of the
study.
2.3. Cholinesterases activity and characterization
Small pieces of the tissue were cut and repeatedly
washed with physiological solution and homogenized in
ice-cold buffer. Then homogenates were ﬁltered through
a muslin cloth and centrifuged at 4 ◦C during 5 min
at 4000 × g. AChE and BChE activities were determined
in the supernatant according to the method of Ellman
et al. [18]. In a typical assay, 2.6 ml  of 0.1 M phosphate
buffer pH 8, 100 l of 0.01 M DTNB and 400 l of the
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ample supernatant were successively added in a standard
uvette. Measurement of enzyme activity was  initiated
y the addition of 20 l of freshly prepared 75 mM ASCh
odide solution in distilled water. Absorption of the 2-
itro-5-thiobenzoate anion, formed from the reaction, was
ecorded at 412 nm for 2 min  at 30 ◦C. Spontaneous sub-
trate hydrolysis was assessed using a blank without
ample. Kinetic was calculated in the linear range. Each
ample was analyzed by triplicates. Protein concentration
as determined according to Lowry et al. [19].
The enzymatic activity was expressed as mol  of sub-
trate hydrolyzed per minute per mg  of protein, using a
olar extinction coefﬁcient of 1.36 × 10−3 M−1 cm−1.
The characterization of ChE was carried out using the
ollowing substrates: ASCh (considered non-selective) and
SCh (speciﬁc for BChE). Substrate concentrations varied
rom 37.5 to 150 mM (ﬁnal concentrations in the cuvette:
.24–0.96 mM).  In the selective inhibitor experiments, all
nzymatic activities were determined using ASCh as sub-
trate at the 75.0 mM concentration (ﬁnal concentration
n the cuvette: 0.48 mM).  The following inhibitors were
sed: eserine sulphate, BW284C51 and iso-OMPA, which
electively inhibit total ChEs, AChE, and BChE, respectively.
inal inhibitor concentrations were 1.25–25 M for eser-
ne, 0.85–13.20 M for BW284C51, and 1.00–64.00 M for
so-OMPA. Stock solutions of eserine and BW284C51 were
repared in water, and iso-OMPA stock solution was dis-
olved in ethanol. Each inhibitor solution (5 L) was mixed
ith 495 L of the homogenate and incubated at room tem-
erature for 20 min  as described by Nunes et al. [20]. Water
as used as a control, and an additional control was pre-
ared with ethanol for the samples exposed to iso-OMPA.
ll the experiments were performed in triplicate.
.4. Gradient gel electrophoresis
A total of 0.12 g of placenta, containing about 0.9 mg
rotein, were cut in small pieces, repeatedly washed with
hysiological solution and homogenized on ice with 1.5 M
ris–HCl buffer pH 8.8. Then, the homogenate was  ﬁltered
hrough a muslin cloth and centrifuged at 4 ◦C during 5 min
t 4000 × g. The supernatant was mixed with an equal
olume of 50% glycerol, 0.1 M Tris–HCl, pH 7.5 and bro-
ophenol blue before loading on the gel with the sample
ontaining 10 g of protein [19] per line. Four to thirty per-
ent polyacrylamide gels, 0.75 mm were poured in a Hoefer
el apparatus [21]. Electrophoresis was run at 250 V for 20 h
t 4 ◦C.
For the population study, fourteen samples (PP) and
en samples (RP) chosen at random in each group were
rocessed as describe above.
The study population for electrophoresis analysis
onsisted of fourteen samples (PP) and ten samples (RP)
hosen at random in each group.
.5. Staining for AChE and BChE activitiesThe method of Karnovsky [22] adapted to polyacrylam-
de gels by Li et al. [21] was used. The staining solution
ontained 180 ml  of 0.2 M maleic acid adjusted to pH 6.0
ust before use, 15 ml  of 0.10 M sodium citrate, 30 ml  oforts 2 (2015) 437–442 439
0.030 M CuSO4, 30 ml  water, 30 ml  of 5 mM potassium
ferricyanide, and 150 mg of ASCh iodide or 171 mg  of
BSCh iodide. AChE puriﬁed from electric organ tissue of
Electrophorus electricus was  used as a staining technique
control. Gels were incubated for 5 h, or overnight, with gen-
tle shaking until brown-red bands of activity developed.
2.6. Identiﬁcation of ChEs bands on gels
Gels stained with ASCh revealed both AChE and BChE
because both enzymes have high activity with ASCh. On
the other hand, gels stained with BSCh identiﬁed BChE. In
addition, comparison with human serum bands allowed
the identiﬁcation of BChE according to the attachment of
structural subunits.
2.7. Data analysis
An analysis of variance (ANOVA) was  performed to com-
pare differences between the inhibitor and the substrate
concentrations. The comparison between the two types of
substrates at same concentration and between PR and PP
samples was made using the Students t-test. All statistical
analyses were performed using R software version 2.6.0.
Statistical signiﬁcance was assumed as p < 0.05.
3. Results
3.1. Characterization of placental ChEs in control samples
The characterization of the ChEs activities included a
ﬁrst step to distinguish ChEs from non-speciﬁc esterases
using in vitro incubations with speciﬁc inhibitors of ChEs.
Fig. 1A shows that ChEs activities were almost totally
inhibited by eserine. Speciﬁc inhibitors were used, an
important decrease of BChE and AChE enzymatic inhibition
was observed, reaching a plateau at about at 3.3 × 10−6 M
(Fig. 1B) and 16 × 10−6 M (Fig. 1C), respectively.
The preference of placenta homogenate samples using
ASCh or BSCh as substrates is shown in Fig. 2. Lower
enzymatic activities were observed when using BSCh as
substrate at all the evaluated concentrations (ASCh > BSCh
(p < 0.05)).
3.2. Identiﬁcation of a unique placental ChE band on gels
from control samples
Fig. 3 shows the migration of the bands correspond-
ing to control placenta samples, human plasma sample
and commercial E. electricus AChE. Enzyme activities were
revealed in the presence of the BChE-speciﬁc substrate,
BSCh (Fig. 3A) and in the presence of ASCh (Fig. 3B). In
both gels, monomer, dimer, and tetramer bands of serum
BChE were revealed; while a unique band at the same
location of BChE plasma tetramer, was stained in placenta
samples.3.3. Population study
The characteristics of the study groups as well as the
blood ChE activities were reported previously [23]. Brieﬂy,
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Fig. 1. Effect of speciﬁc inhibitors of cholinesterase activity. Activity was
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Fig. 2. Substrate preference of cholinesterases from total placenta
homogenates. Results are presented as means ± SD of three placenta sam-
ples in triplicates each of them. ASCh vs. BSCh: t-test **p < 0.05.
Table 1
The results were expressed as mean ± SD.
Cholinesterase activity
RP (n = 18) 9.28 ± 4.99
PP (n = 22) 16.34 ± 5.51**
Cholinesterase activity in placenta homogenate was expressed as moldetermined by the Ellman assay using ASCh 0.48 mM as substrate. Results
are presented as means ± SD of three placenta samples (s1, s2 and s3) in
triplicates each of them. ANOVA: ***p < 0.0001.PP and PR groups were similar in terms of demographical
characteristics and habits. Only 1.2% (RP) reported alcohol
consumption (less than two alcoholic beverages/week) and
5% and 6.2% (RP and PP, respectively) had smoked during
Fig. 3. Non-denaturing gel stained for activity with BSCh (A) and ASCh(B).
(A)  and (B) line 1, AChE Electric Eel. Lines 2 and 5, human plasma samples. Lines
disulﬁde-bonded dimer between one subunit of BChE and one molecule of albumof  substrate hydrolyzed/mg protein−1 min−1. Activity was determined by
the Ellman assay using ASCh 0.48 mM as substrate.
** p < 0.001, t-test.
pregnancy. Comparing the average blood ChE activity of RP
vs. PP, plasma BChE decreased signiﬁcantly (20%, p < 0.01),
suggesting maternal anticholinesterase pesticide exposure
in PP.
3.4. Environmental OP exposition increased placental
ChE activity
As shown in Table 1, placental ChE activity was  affected
by the sampling period. The average ChE activity of placen-
tal homogenates increased signiﬁcantly 76% (p < 0.001) in
PP.3.5. Environmental OP exposition increased BChE band
A representative gel of placenta samples from RP and
PP groups is shown in Fig. 4. The comparison of RP sample
 3 and 4, placenta homogenate samples. The band labeled BChE-alb is a
in.
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omogenates. Values obtained for the optical densities were: 0.29; 0.53 a
line 1) and PP samples (lines 2 and 3) demonstrated a
igher intense band in RP sample and suggest the same
ocation of BChE plasma tetramer.
. Discussion
.1. Placental ChE characterization
As expected, in the present study the measured enzy-
atic activity in placenta homogenates was almost fully
nhibited by eserine hemisulfate (Fig. 1A). The results
bserved with this generic inhibitor of ChE, conﬁrmed pre-
ious reports. Our results, are also in consonance with
hose of Fant and Harbison [24] and Derewlany et al. [25]
ho previously showed activity on both ChE from differ-
nt subcellular fractions of placenta. Inhibitors incubations
howed that one of them presents the properties of a verte-
rate BChE: high sensitivity to eserine hemisulfate (Fig. 1A)
nd iso-OMPA (Fig. 1C). It must be noted that the incu-
ation with the chemical iso-OMPA, speciﬁc inhibitor of
ChE, resulted in signiﬁcant but non complete inhibition.
his result suggested that the remaining activity reﬂects
he relative contribution of AChE to ASCh hydrolysis. In
act, there was another which presents all the proper-
ies of a vertebrate AChE: high sensitivity to eserine and
W284c51 (Fig. 1B). Also, a partial sensitivity to BW284c51
as observed for AChE.
As stated, enzymatic activity using ASCh represents
ombined AChE and BChE activities. Therefore, the
ubstrates preference of placenta homogenate samples
uggests that BChE contributed almost to the 75% to the
otal ChE hydrolysis of ASCh (Fig. 2). In accordance with
he substrates preference assay, the non-denaturing gradi-
nt gel electrophoresis of placenta samples revealed only
ne band when stained with both AChE (Fig. 3A) and BChE
Fig. 3B), showing that BChE activity represents total pla-
ental ChEs activity detected by this method. In agreement,
he content of ChE mRNAs by RT-PCR in human kidney
amples, showed that this organ possesses abundant BChE
ctivity and less AChE activity in the form of GPI-anchored
pecies [26]. Also, it was reported that AChE activity in micemogenate sample (RP). Lines 2 and 3 homogenate samples (PP). Lines 4
resents the densitometry quantiﬁcation of protein levels in the placenta
.
predominates only in the brain while BChE activity is higher
in intestine, serum, lung, liver, and heart [27].
Comparison with recognized bands of plasma BChE
isoforms [21], the band position strongly suggests that
tetrameric BChE is the predominant ChE form in placen-
tal homogenate. It was  reported that BChE can occurs as
various globular forms (G1, G2 and G4), as amphiphilic or
hydrophilic variants. The latest form is abundant for BChE
in mammalian body ﬂuids and in the soluble fraction of
tissue homogenates [28].
Our results differ from that of Hahn et al. [11] who
found higher AChE activity than BChE activity in cultured
explanted villous of term placenta. It must be noted that
although placental explant cultures are useful for studying
tissue functions, experimental conditions such as concen-
trations of ions and nutrients in culture media can have
important implications for villous function [29]. In addi-
tion, Hahn et al. [11] used a higher speed supernatant
(16,000 rpm) as a enzymatic source than the one from the
present study (5,700 rpm).
In summary, we  propose that in human placenta
homogenates, ChE activity mostly corresponds to BChE on
the basis of its inhibition with iso-OMPA, substrate prefer-
ences and non-denaturating gel electrophoresis mobility.
Minor AChE activity was  also detected.
In the current work, placental ChE increased in PP
respect to RP samples, reproducing our previous ﬁnding in
placenta of women  living in the same area [14]. In addition,
the comparative analysis of the position and intensity of a
unique band in non-denaturing gel of PP and RP samples
suggests that BChE tetramer is behind the increase in pla-
cental ChE activity. Instead, we previously reported lower
blood BChE activity associated to PP in the participants
included in the present study [23].
Using the same analytical method, Duysen et al. [30]
showed trimers or dimers of AChE in plasma of mice intox-
icated with different OPs. Mice treated with OP responded
with the classic signs of OP exposure. In the ﬁrst hours and
days after OP treatment, plasma AChE and BChE activities
were inhibited. Over the next few days, both activities were
recovered. After that, the AChE activity was  increased to
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2.5-fold above of the normal activity. Herein, we demon-
strated for the ﬁrst time that OP environmental exposure is
associated to BChE up regulation in a non-innervated tis-
sue. In summary, the current study strongly suggest that
an up regulation of placental BChE, recognized as the ﬁrst
line of defense against poisons and drugs [31] is associ-
ated to environmental OP exposure. We  propose that it
represents an adaptive change in BChE gene expression
as mediator of recovery from chemical OP insults. As it
appears that BChE has two principal functions: detoxiﬁ-
cation and acetylcholine hydrolysis [32], it remains to be
elucidated whether this response might affect cholinergic
system function in placenta.
Transparency document
The Transparency document associated with this article
can be found in the online version.
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